Sage Journals: Discover world-class research

Retricted access

Research article

First published 2009-5

Telavancin: A Novel Lipoglycopeptide Antibiotic

Lisa Charneski, Priti N Patel, Donna Sym

Annals of Pharmacotherapy

Retricted access

Research article

First published 2015-7

Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags

Zhengtian Gu, Anissa Wong, Elvira Raquinio [...]

Hospital Pharmacy

Free access

Review article

First published 2017-3

Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens

Biswadeep Das, Chayna Sarkar, Debasmita Das [...]

Therapeutic Advances in Infectious Disease

Retricted access

Case report

First published 2012-6

Successful Treatment of Polymicrobial Calcaneal Osteomyelitis with Telavancin,Rifampin,and Meropenem

Mary Beth Brinkman, Kaili Fan, Renee L Shiveley [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2009-10

Telavancin and Hydroxy Propyl-β-Cyclodextrin Clearance during Continuous Renal Replacement Therapy: An in vitro Study

Jignesh H. Patel, Mariann D. Churchwell, Julie D. Seroogy [...]

The International Journal of Artificial Organs

Retricted access

Research article

First published 2013-08

Studies on the Mechanism of Telavancin Decreased Susceptibility in a Laboratory-Derived Mutant

Yang Song, Christopher S. Lunde, Bret M. Benton [...]

Microbial Drug Resistance

Free access

Review article

First published 2016-8

Telavancin in the treatment of Staphylococcus aureus hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience

Adamantia Liapikou, Katerina Dimakou, Michael Toumbis

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2010-2

Telavancin

Dennis J. Cada, Terri L. Levien, Danial E. Baker

Hospital Pharmacy

Retricted access

Research article

First published 2020-08

Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens,Including Multidrug-Resistant Isolates (2015–2017)

Leonard R. Duncan, Helio S. Sader, Michael D. Huband [...]

Microbial Drug Resistance

Open access

Research article

First published 2017-09

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions

Michael A. Pfaller, Helio S. Sader, Robert K. Flamm [...]

Microbial Drug Resistance

Search results